国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methylobacillus flagellatus tRNA threonylcarbamoyladenosine biosynthesis protein RimN (rimN) CSB-YP627916MAAN
CSB-EP627916MAAN
CSB-BP627916MAAN
CSB-MP627916MAAN
CSB-EP627916MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus 50S ribosomal protein L17 (rplQ) CSB-YP627917MAAN
CSB-EP627917MAAN
CSB-BP627917MAAN
CSB-MP627917MAAN
CSB-EP627917MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus 50S ribosomal protein L15 (rplO) CSB-YP627918MAAN
CSB-EP627918MAAN
CSB-BP627918MAAN
CSB-MP627918MAAN
CSB-EP627918MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus 50S ribosomal protein L24 (rplX) CSB-YP627919MAAN
CSB-EP627919MAAN
CSB-BP627919MAAN
CSB-MP627919MAAN
CSB-EP627919MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus 50S ribosomal protein L23 (rplW) CSB-YP627920MAAN
CSB-EP627920MAAN
CSB-BP627920MAAN
CSB-MP627920MAAN
CSB-EP627920MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus 30S ribosomal protein S7 (rpsG) CSB-YP627921MAAN
CSB-EP627921MAAN
CSB-BP627921MAAN
CSB-MP627921MAAN
CSB-EP627921MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus Elongation factor Tu 1 (tuf1) CSB-YP627922MAAN
CSB-EP627922MAAN
CSB-BP627922MAAN
CSB-MP627922MAAN
CSB-EP627922MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus ATP phosphoribosyltransferase (hisG) CSB-YP627923MAAN
CSB-EP627923MAAN
CSB-BP627923MAAN
CSB-MP627923MAAN
CSB-EP627923MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP627924MAAN
CSB-EP627924MAAN
CSB-BP627924MAAN
CSB-MP627924MAAN
CSB-EP627924MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus Ribosomal RNA large subunit methyltransferase F (rlmF) CSB-YP627925MAAN
CSB-EP627925MAAN
CSB-BP627925MAAN
CSB-MP627925MAAN
CSB-EP627925MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bos gaurus frontalis Somatotropin (GH1) CSB-YP627926BIR
CSB-EP627926BIR
CSB-BP627926BIR
CSB-MP627926BIR
CSB-EP627926BIR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Canis lupus NADH-ubiquinone oxidoreductase chain 5 (MT-ND5), partial CSB-YP627927CCW
CSB-EP627927CCW
CSB-BP627927CCW
CSB-MP627927CCW
CSB-EP627927CCW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bombyx mori Tropomyosin-2 CSB-YP627928BTT
CSB-EP627928BTT
CSB-BP627928BTT
CSB-MP627928BTT
CSB-EP627928BTT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aedes aegypti Probable dynactin subunit 2 (Dmn) CSB-YP627929AXQ
CSB-EP627929AXQ
CSB-BP627929AXQ
CSB-MP627929AXQ
CSB-EP627929AXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aedes aegypti Eukaryotic translation initiation factor 3 subunit E (eIF3-S6) CSB-YP627930AXQ
CSB-EP627930AXQ
CSB-BP627930AXQ
CSB-MP627930AXQ
CSB-EP627930AXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sturnira erythromos Cytochrome b (MT-CYB), partial CSB-YP627931SBAP
CSB-EP627931SBAP
CSB-BP627931SBAP
CSB-MP627931SBAP
CSB-EP627931SBAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vampyrodes caraccioli NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP627932VAAI1
CSB-EP627932VAAI1
CSB-BP627932VAAI1
CSB-MP627932VAAI1
CSB-EP627932VAAI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Protease precursor (BVRF2), partial CSB-YP627933EEZ
CSB-EP627933EEZ
CSB-BP627933EEZ
CSB-MP627933EEZ
CSB-EP627933EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Envelope glycoprotein M (gM), partial CSB-YP627934EEZ
CSB-EP627934EEZ
CSB-BP627934EEZ
CSB-MP627934EEZ
CSB-EP627934EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Protein BMRF2 (BMRF2), partial CSB-YP627935EEZ
CSB-EP627935EEZ
CSB-BP627935EEZ
CSB-MP627935EEZ
CSB-EP627935EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>